We are live on ! Find out more
ATEC icon

Alphatec Holdings

10.58 USD
+1.74
19.68%
At close Updated Sep 11, 4:00 PM EDT
Pre-market
After hours
10.63
+0.05
0.47%
1 day
19.68%
5 days
14.75%
1 month
12.91%
3 months
30.14%
6 months
-16.43%
Year to date
-49.04%
1 year
-32.31%
5 years
-24.64%
10 years
135.11%
 

About: Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.

Employees: 913

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 25%
Neutral 62.5%
Negative 12.5%
Positive
Seeking Alpha
1 month ago
Alphatec: Straightening Its Back
Alphatec reports 15% revenue growth and improved operating leverage, with realistic break-even levels approaching despite ongoing net losses and dilution. Alphatec maintains $882 million in sales guidance and raises adjusted EBITDA guidance to $140 million, signaling confidence in margin improvements and operational progress. Leverage concerns are easing as free cash flow turns positive, dilution slows, and interest expenses decline, aided by strong EOS imaging technology growth.
Alphatec: Straightening Its Back
Neutral
Seeking Alpha
1 month ago
Alphatec Holdings, Inc. (ATEC) Q2 2026 Earnings Call Transcript
Alphatec Holdings, Inc. (ATEC) Q2 2026 Earnings Call Transcript
Alphatec Holdings, Inc. (ATEC) Q2 2026 Earnings Call Transcript
Negative
Zacks Investment Research
1 month ago
Alphatec (ATEC) Q2 Earnings Lag Estimates
Alphatec (ATEC) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.02 per share a year ago.
Alphatec (ATEC) Q2 Earnings Lag Estimates
Positive
MarketBeat
1 month ago
Alphatec Q2 Earnings Call Highlights
Alphatec NASDAQ: ATEC reported second-quarter 2026 revenue of $214 million, up 15% from a year earlier, as growth in surgical procedures and surgeon adoption supported higher profitability and positive free cash flow.
Alphatec Q2 Earnings Call Highlights
Neutral
Business Wire
1 month ago
ATEC Reports Second Quarter Financial Results
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended June 30, 2026, and business highlights. Second Quarter 2026 Financial Results Quarter Ended June 30, 2026 Total revenue $214 million GAAP gross margin 72.2% Non-GAAP gross margin 72.5% GAAP operating expenses $156 million Non-GAAP operating expenses $135 mill.
ATEC Reports Second Quarter Financial Results
Neutral
Business Wire
1 month ago
ATEC Announces Participation in Upcoming Investor Conferences
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conference(s): Management will host one-on-one investor meetings at the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Monday, August 10, 2026. Management will present to investors at the 19th Annual Piper Sandler MedTech and Dia.
ATEC Announces Participation in Upcoming Investor Conferences
Neutral
Business Wire
2 months ago
ATEC to Report Second Quarter 2026 Financial Results on August 4, 2026
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report second quarter 2026 financial results on August 4, 2026, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET.WebcastTo access the live webcast, please use this link or visit the Investor Relations Events & Presentations section of ATEC's cor.
ATEC to Report Second Quarter 2026 Financial Results on August 4, 2026
Neutral
GlobeNewsWire
2 months ago
Alphatec Holdings Investor Alert: Johnson Fistel Reviews Potential Claims for Shareholders
SAN DIEGO, July 07, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating Alphatec Holdings, Inc. (NASDAQ: ATEC) on behalf of investors who suffered losses and whether those losses may be recoverable under federal securities laws.
Alphatec Holdings Investor Alert: Johnson Fistel Reviews Potential Claims for Shareholders
Neutral
PRNewsWire
3 months ago
ATEC Investors Have Opportunity to Join Alphatec Holdings, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES, June 11, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Alphatec Holdings, Inc. ("Alphatec" or "the Company") (NASDAQ: ATEC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
ATEC Investors Have Opportunity to Join Alphatec Holdings, Inc. Fraud Investigation with the Schall Law Firm
Positive
The Motley Fool
3 months ago
Alphatec vs. Inspire Medical Systems: Which Healthcare Stock Is a Better Buy in 2026?
Alphatec focuses on a comprehensive spine surgery ecosystem to capture market share through integrated imaging and surgical solutions. Inspire Medical Systems dominates the sleep apnea neurostimulation market with a profitable, high-growth business model.
Alphatec vs. Inspire Medical Systems: Which Healthcare Stock Is a Better Buy in 2026?
Price charts implemented using Lightweight Charts™